Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)
CUSIP: 29384C108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 38,346,880
- Total 13F shares
- 29,668,185
- Share change
- +3,649,461
- Total reported value
- $422,803,373
- Price per share
- $14.25
- Number of holders
- 82
- Value change
- +$52,052,901
- Number of buys
- 56
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 29384C108?
CUSIP 29384C108 identifies TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29384C108:
Top shareholders of TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
13%
|
4,865,819
|
$68,948,655 | — | 31 Mar 2024 | |
| MPM ASSET MANAGEMENT LLC |
13F
|
Company |
12%
|
4,425,784
|
$62,713,359 | — | 31 Mar 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
11%
|
4,408,379
|
$62,466,730 | — | 31 Mar 2024 | |
| ROCHE HOLDING LTD |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,813,525
|
$44,988,265 | — | 02 Nov 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
7.2%
|
2,753,357
|
$39,016,000 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
3/4/5
13F
|
10%+ Owner · Company |
3.3%
from 13F
|
1,954,420
|
$31,251,176 | — | 02 Nov 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.9%
|
1,486,168
|
$21,059,002 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
1,078,908
|
$15,288,126 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.7%
|
1,026,840
|
$14,550,323 | — | 31 Mar 2024 | |
| StepStone Group LP |
13F
|
Company |
2%
|
761,277
|
$10,787,295 | — | 31 Mar 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
1.5%
|
584,955
|
$8,288,812 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
475,358
|
$6,736,526 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
435,390
|
$6,169,476 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.96%
|
366,348
|
$5,191,151 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.52%
|
199,342
|
$2,824,676 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.44%
|
167,921
|
$2,379,441 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.41%
|
156,629
|
$2,219,433 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
110,598
|
$1,567,174 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.28%
|
107,562
|
$1,524,153 | — | 31 Mar 2024 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.27%
|
105,000
|
$1,487,850 | — | 31 Mar 2024 | |
| Advantage Alpha Capital Partners LP |
13F
|
Company |
0.24%
|
91,116
|
$1,291,114 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
71,946
|
$1,019,475 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.19%
|
71,308
|
$1,010,434 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
69,676
|
$987,309 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.15%
|
57,137
|
$809,631 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.15%
|
56,287
|
$797,587 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.14%
|
54,952
|
$778,670 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.13%
|
51,723
|
$732,915 | — | 31 Mar 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.13%
|
49,082
|
$695,492 | — | 31 Mar 2024 | |
| Nerissa Kreher |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
61,537
mixed-class rows
|
$640,192 | — | 01 Sep 2023 | |
| Corton Capital Inc. |
13F
|
Company |
0.11%
|
41,142
|
$582,982 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.09%
|
34,101
|
$483,211 | — | 31 Mar 2024 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.08%
|
32,555
|
$461,304 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.08%
|
30,784
|
$436,209 | — | 31 Mar 2024 | |
| NATIXIS |
13F
|
Company |
0.08%
|
31,186
|
$432,862 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
29,488
|
$417,834 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.08%
|
28,951
|
$410,235 | — | 31 Mar 2024 | |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.07%
|
25,914
|
$367,201 | — | 31 Mar 2024 | |
| STRS OHIO |
13F
|
Company |
0.07%
|
25,700
|
$364,000 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
23,469
|
$332,556 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.06%
|
23,000
|
$325,910 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
22,565
|
$319,745 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
22,517
|
$319,066 | — | 31 Mar 2024 | |
| MARTINGALE ASSET MANAGEMENT L P |
13F
|
Company |
0.05%
|
18,452
|
$261,466 | — | 31 Mar 2024 | |
| Oracle Alpha Inc. |
13F
|
Company |
0.05%
|
17,341
|
$245,722 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
17,323
|
$245,470 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.04%
|
16,809
|
$238,184 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.04%
|
16,052
|
$227,457 | — | 31 Mar 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.04%
|
14,763
|
$209,192 | — | 31 Mar 2024 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.04%
|
14,543
|
$206,000 | — | 31 Mar 2024 |
Institutional Holders of Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) as of Q2 2024
As of 30 Jun 2024,
Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,668,185 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, MPM ASSET MANAGEMENT LLC, 5AM Venture Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, and StepStone Group LP.
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
76
Q2 2024 holders
82
Holder diff
6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.